anakinra

  1. forestglip

    Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: [RCT], 2021, Kyriazopoulou et al

    Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial (SAVE-MORE trial) Abstract Early increase of soluble urokinase plasminogen activator receptor (suPAR) serum levels is indicative of...
  2. forestglip

    Open Germany, Greece, Italy, Spain: Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome (PRECISION)

    Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome (PRECISION) Description People with COVID-19 might have sustained post-infection sequelae, known as Post-Acute Covid Syndrome (PACS). A recent consensus definition by an international panel of 265 patients...
  3. Mij

    Proximal immune-epithelial progenitor interactions drive chronic tissue sequelae post COVID-19, 2023, Harish Narasimhan et al

    Abstract The long-term health effects of SARS-CoV-2, termed Post-Acute Sequelae of COVID-19 (PASC), are quickly evolving into a major public health concern, but the underlying cellular and molecular etiology remain poorly defined. There is growing evidence that PASC is linked to abnormal immune...
Back
Top Bottom